The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,113,915 in first-year total cost, median $232,125.
Most frequent study sections
- Oral, Dental and Craniofacial Sciences Study Section[ODCS]2
- Cancer Immunopathology and Immunotherapy Study Section[CII]1
- Musculoskeletal Tissue Engineering Study Section[MTE]1
- Special Emphasis Panel[ZRG1 OTC-M (08)]1
Most frequent institutions
- MEDICAL UNIVERSITY OF SOUTH CAROLINA1
- UNIVERSITY OF KENTUCKY1
- UNIVERSITY OF MINNESOTA1
- VIRGINIA COMMONWEALTH UNIVERSITY1
- WAKE FOREST UNIVERSITY HEALTH SCIENCES1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Wnt3a is a central regulator for P. gingivalis-mediated expression of PD-L1 and suppression of CD8+ T cell activity1R21DE031376-01A1 | WANG, HUIZHI | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $232,875 | ODCS |
| 2022 | Precise Modulation of Immunometabolism to Boost Antibody Therapy in Oral Cancer1R21DE032183-01 | MING, XIN | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $232,500 | CII |
| 2022 | Magnetic nanocomplexes-induced immunomodulation for fracture healing1R21AR078447-01A1 | TIRUVANNAMALAI ANNAMALAI, RAMKUMAR | UNIVERSITY OF KENTUCKY, KY | $192,165 | MTE |
| 2021 | Calprotectin and CD69 affect regulatory T cell responses in periodontal disease1R21DE029601-01A1 | COSTALONGA, MASSIMO | UNIVERSITY OF MINNESOTA, MN | $232,125 | ODCS |
| 2020 | Defining the role of CD26 in checkpoint blockaded induced tumor immunity1R21DE029592-01 | NESKEY, DAVID M.PAULOS, CHRYSTAL MARY | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $224,250 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.